Literature DB >> 29648995

Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis.

Harald Hegen1, Dejan Milosavljevic2, Christine Schnabl2, Andrea Manowiecka2, Janette Walde3, Florian Deisenhammer1, Stefan Presslauer4.   

Abstract

BACKGROUND: Free light chains (FLC) have been proposed as diagnostic biomarker in patients with inflammatory central nervous system diseases. The objective of this study was to investigate the diagnostic utility of intrathecal κ- and λ-FLC synthesis in patients with neuroborreliosis.
METHODS: κ- and λ-FLC were measured by nephelometry under blinded conditions in cerebrospinal fluid (CSF) and serum sample pairs of 34 patients with neuroborreliosis and compared to a cohort of 420 control patients. κ-FLC index was calculated as [CSF κ-FLC/serum κ-FLC]/[CSF albumin/serum albumin], and λ-FLC index in analogy.
RESULTS: κ-FLC and λ-FLC index were significantly elevated in patients with neuroborreliosis compared to the control group. At a specificity level of 95%, κ-FLC and λ-FLC index showed a diagnostic sensitivity of 88.2% and 100%. In comparison, IgM and IgG synthesis according to Reiber formula, IgG index >0.7 and OCB status reached a sensitivity of 83.9%, 44.1%, 58.8% and 64.7%.
CONCLUSION: These findings support the diagnostic value of intrathecal FLC synthesis in neuroborreliosis patients and demonstrate a valid, easy and rater-independent alternative for the detection of an intrathecal immunoglobulin production.

Entities:  

Keywords:  IgA; IgG; IgM; cerebrospinal fluid; free light chain; intrathecal synthesis; neuroborreliosis; oligoclonal bands; serum

Mesh:

Substances:

Year:  2018        PMID: 29648995     DOI: 10.1515/cclm-2018-0028

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.

Authors:  Harald Hegen; Klaus Berek; Florian Deisenhammer
Journal:  Wien Med Wochenschr       Date:  2022-02-08

Review 2.  Immunoserological Diagnosis of Human Borrelioses: Current Knowledge and Perspectives.

Authors:  Emilie Talagrand-Reboul; Alice Raffetin; Pierre Zachary; Benoît Jaulhac; Carole Eldin
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

Review 3.  The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Kurt-Wolfram Sühs; Hayrettin Tumani; Marie Süße; Thomas Skripuletz
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

4.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association.

Authors:  Franziska Di Pauli; Paul Morschewsky; Klaus Berek; Michael Auer; Angelika Bauer; Thomas Berger; Gabriel Bsteh; Paul Rhomberg; Kathrin Schanda; Anne Zinganell; Florian Deisenhammer; Markus Reindl; Harald Hegen
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

5.  Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Torsten Witte; Kurt-Wolfram Sühs; Matthias Grothe; Malte Johannes Hannich; Marie Süße; Thomas Skripuletz
Journal:  Brain Sci       Date:  2022-04-03

6.  Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.

Authors:  Sawsan Feki; Mariem Damak; Salma Sakka; Yesmine Ben Ali; Sabrina Mejdoub; Nadia Bouattour; Hend Hachicha; Chokri Mhiri; Hatem Masmoudi
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

Review 7.  Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection.

Authors:  Monika Gudowska-Sawczuk; Barbara Mroczko
Journal:  Biomed Res Int       Date:  2019-12-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.